Stem Cell Sciences wins UK patent covering enzyme inhibitor cocktail

Stem Cell Sciences to license green florescent protein technology

Stem Cell Sciences adds mouse Nanog methods to IP portfolio

Stem Cell Sciences adds pericyte cell types to list of products for research.

Dr Jenny Harry has been appointed CEO of Proteome Systems and has announced a new $5m deal.

Following a rancorous and polarising public debate last year, the creation of embryonic stem cell lines through somatic cell nuclear transfer will become legal in Australia on June 12.

Stem Cell Sciences (SCS) has licensed the use of its novel mouse neural stem cell technology to Merck & Co for research use.

Melbourne-based Stem Cell Sciences (SCS) has signed an exclusive license agreement with the US Millipore Corporation to develop and market SCS' serum-free media for the growth of human embryonic stem cells (hESCs).

Stem Cell Sciences (AIM:STEM, SCS) and Californian-based Chemicon are set to launch a new product line of culture media for mouse embryonic stem cells.

Stem Cell Sciences (AIM:STEM, SCS) has signed a new tech transfer agreement with the University of Edinburgh, building on a formal collaboration begun in 1994.

Stem Cell Sciences KK (SCS KK), a Japanese affiliate of Stem Cell Sciences (AIM:STEM, SCS), has signed a worldwide exclusive license agreement with the University of Nice to commercialise tissue stem cells that may have therapeutic application in degenerative diseases such as Duchenne Muscular Dystrophy (DMD).